US FDA moves to boost domestic drug manufacturing after Trump push

FDA Moves to Strengthen Drug Supply Chain with PreCheck Program

The agency’s new program is designed to increase regulatory predictability and streamline review of domestic manufacturing facilities.

FDA moves to boost domestic drug supply

The FDA launches FDA PreCheck to streamline pharmaceutical plant regulation, aiming to boost domestic drug manufacturing and reduce reliance on foreign production.

FDA to Boost Domestic Pharmaceutical Production

The Food and Drug Administration (FDA) unveiled a new plan to boost the nation’s domestic pharmaceutical supply. “Our gradual overreliance on foreign drug manufacturing has created national security risks,” said FDA Commissioner Marty Makary. “The FDA PreCheck initiative is one of many steps FDA is taking that can help reverse America’s reliance on foreign drug manufacturing and ensure that Americans have a resilient, strong, and domestic drug s…

FDA makes it easier to set up US manufacturing sites

The FDA has launched a programme to make it easier to set up manufacturing facilities in the US and reduce the country's reliance on imported drugs

FDA Fast-Tracks Domestic Drug Manufacturing with PreCheck

The FDA introduces ‘PreCheck,’ a program aiming to expedite the construction and review of drug manufacturing plants in the U.S. This initiative seeks to boost domestic drug supply, aligning with governmental goals to reduce dependency on foreign sources. Major pharmaceutical companies support this push with significant investments.

FDA launches program to encourage American drug manufacturing

The U.S. Food and Drug Administration announced Thursday it is launching "FDA PreCheck" in order to help construct drug manufacturing sites in the United States.